Skip to contentSkip to Braille Studio

Library / Laws / 119th Congress / House Bills / H.R. 1117

H.R. 1117

To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.

Print stageDateSize⠃
Introduced in House2025-02-072.9K⠃⠗⠋